IMS Health, Inc. just announced that it is acquiring SDI. Below is the media statement. These are turbulent times for companies like IMS. As reflected in the post below, the U.S. Supreme Court agreed to take a case in which the State of Vermont seeks to prohibit companies such as IMS from collecting and selling "prescriber-identifiable data." Such data-mining identifies doctors, links the doctor to a particular prescription, and reveals other details about that prescription. Often, pharma companies use this information to determine whether the off-label marketing techniques are working.
IMS Stmt (Acquiring SDI)